|
US2020368394A1
|
|
Compositions and methods for restoring or preventing loss of vision caused by disease or traumatic injury
|
|
WO2018231882A1
|
|
Implants, methods for making implants and methods of treating lipoatrophy defects therewith
|
|
WO2017214342A1
|
|
Improved methods for detecting and modulating the embryonic-fetal transition in mammalian species
|
|
AU2017246580A1
|
|
Pluripotent stem cell-derived 3D retinal tissue and uses thereof
|
|
CA3007733A1
|
|
Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
|
|
US2018369391A1
|
|
Hydrogel foams and methods of making and using the same
|
|
US2015275177A1
|
|
Methods For Generating Pluripotent Stem Cell-Derived Brown Fat Cells
|
|
CA2914615A1
|
|
Compositions and methods for induced tissue regeneration in mammalian species
|
|
US2014341842A1
|
|
Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
|
|
EP2716751A1
|
|
Differentiated progeny of clonal progenitor cell lines
|
|
US2014099712A1
|
|
Methods and compositions for targeting progenitor cell lines
|
|
US2013115673A1
|
|
Methods of Screening Embryonic Progenitor Cell Lines
|
|
WO2013036969A1
|
|
Compositions and methods relating to clonal progenitor cell lines
|
|
WO2013010045A1
|
|
Novel methods and formulations for orthopedic cell therapy
|
|
AU2011316830A1
|
|
Methods of modifying transcriptional regulatory networks in stem cells
|
|
AU2010273930A1
|
|
Methods and compositions for in vitro and in vivo chondrogenesis
|
|
WO2007123684A2
|
|
Methods and devices for thawing and/or imaging frozen biological samples
|
|
WO0183731A1
|
|
Methods and compositions for producing donor cells
|
|
AU5533901A
|
|
Systems, kits, and methods of administering synthetic plasma
|
|
US6300322B1
|
|
Plasma-like solution
|
